An independent source of information on U.S. brand name drugs for health professionals

Drugdocs Logo

An independent source of information on U.S. brand name drugs for health professionals

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Cresemba

Chemical Nameisavuconazonium sulfate
Dosage FormCapsule (oral; 186 mg); injection (intravenous; 372 mg)
Drug ClassAntifungals
SystemDigestive, Skin, Respiratory, Nervous
CompanyAstellas Pharma Inc.
Approval Year2015

Indication

  • To treat adults with invasive aspergillosis and invasive mucormycosis, rare but serious infections.
Last updated on 10/27/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Cresemba (isavuconazonium sulfate) Prescribing Information2019Astellas Pharma US, Inc., Northbrook, IL
Document TitleYearSource
Clinical review report: isavuconazole (Cresemba). 2019CADTH